Antimalarials Recommended for All Lupus Patients
Anthony J. Brown, MD
January 22, 2010 —
Use of antimalarial agents can improve survival
with systemic lupus erythematosus and should be given to all patients
with the disease, according to a report in the January 7th issue of Arthritis
& Rheumatism.
During a median follow-up period of 55 months, the mortality rate for
non-users of antimalarial drugs was 11.5%, while that of users was just
4.4% (p < 0.001). Further analysis showed that patients who used the
drugs for more than 2 years had the lowest mortality per 1000
person-years of follow-up — 0.54 deaths, compared to 3.07 in non-users.
Prior research has suggested that antimalarial therapy can help
prevent flare-ups of lupus and reduce overall damage from the disease,
Dr. Bernardo A. Pons-Estel, from Hospital Provincial de Rosario,
Argentina and co-researchers note.
"The beneficial effects of antimalarials in lupus, however, go beyond
disease activity and damage accrual," the authors state. As an example,
they cite a study in Caucasian patients in which antimalarials seemed
"to have a protective effect on survival" with "a reduction in
mortality." Of note, none of the subjects in the study died from
cardiovascular causes, the most common cause of death in untreated
patients, they add.
Is someone finally getting a clue ?
http://www.medscape....warticle/715655
PS: it might be behind a registration wall.
Edited by rwac, 02 February 2010 - 04:34 PM.